🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Phibro Animal Health Corporation (PAHC)

NASDAQ
Currency in USD
23.39
+0.18(+0.78%)
Real-time Data
PAHC Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
23.2123.70
52 wk Range
10.0425.98
Key Statistics
Edit
Prev. Close
23.21
Open
23.36
Day's Range
23.21-23.7
52 wk Range
10.04-25.98
Volume
30.09K
Average Volume (3m)
187.74K
1-Year Change
109.48%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PAHC Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
18.40
Downside
-21.33%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period
Show more

Phibro Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal’s health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock’s diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Employees
1920

Compare PAHC to Peers and Sector

Metrics to compare
PAHC
Peers
Sector
Relationship
P/E Ratio
54.6x−6.1x−0.7x
PEG Ratio
−3.430.020.00
Price/Book
3.7x2.9x2.6x
Price / LTM Sales
0.9x1.9x3.2x
Upside (Analyst Target)
−13.8%60.3%47.0%
Fair Value Upside
Unlock19.4%7.5%Unlock

Analysts' Recommendations

0 Buy
2 Hold
3 Sell
Ratings:
5 analysts
Overall Consensus
Sell

Analysts 12-Month Price Target:

Average 18.40

(-21.33% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.43
Dividend Yield
2.07%
Industry Median 1.74%
Annualised payout
0.4800
Paid quarterly
5-Years Growth
-
Growth Streak

FAQ

What Is the Phibro (PAHC) Stock Price Today?

The Phibro stock price today is 23.39.

What Stock Exchange Does Phibro Trade On?

Phibro is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Phibro?

The stock symbol for Phibro is "PAHC."

Does Phibro Pay Dividends? What’s The Current Dividend Yield?

The Phibro dividend yield is 2.07%.

What Is the Phibro Market Cap?

As of today, Phibro market cap is 948.19M.

What is Phibro Earnings Per Share?

The Phibro EPS is 0.43.

What Is the Next Phibro Earnings Date?

Phibro will release its next earnings report on 04 Feb 2025.

From a Technical Analysis Perspective, Is PAHC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.